Cambridge, MA, United States of America

Patrick Shannon Pendergrast

This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignee: Ymir Genomics, LLC. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick Shannon Pendergrast. Retrieved from https://idiyas.com/inventor/patrick-shannon-pendergrast

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Patrick Shannon Pendergrast

Introduction

Patrick Shannon Pendergrast is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of biochemistry through his innovative methods for isolating extracellular vesicles and other bioparticles from biofluids. His work has implications for diagnostics and therapeutic target identification.

Latest Patents

Pendergrast holds a patent for "Methods for the isolation of extracellular vesicles and other bioparticles from urine and other biofluids." This patent describes compositions and methods for isolating protein-nucleic acid complexes and microvesicles released by mammalian cells. The isolated bioparticles contain biological molecules that serve as diagnostic or prognostic biomarkers. The methods outlined in the patent also provide ways to produce biofluids that are free of detectable bioparticles, which is useful in various experimental systems.

Career Highlights

Pendergrast is currently associated with Ymir Genomics, LLC, where he continues to advance his research and innovations. His work has garnered attention for its potential to improve diagnostic techniques and therapeutic strategies in medicine.

Collaborations

Some of his notable coworkers include Robert Scott Pendergrast and John Stephen Pendergrast, who contribute to the collaborative efforts at Ymir Genomics, LLC.

Conclusion

Patrick Shannon Pendergrast's innovative work in the isolation of bioparticles represents a significant advancement in the field of biochemistry. His contributions have the potential to enhance diagnostic and therapeutic approaches in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…